Preclinical dose-ranging studies of a novel dry powder norovirus vaccine formulation
Authors:
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulationsVaccine, 2012
- Monoclonal Antibody-Based Antigenic Mapping of Norovirus GII.4-2002Journal of Virology, 2012
- Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccineVaccine, 2011
- Chimpanzees as an animal model for human norovirus infection and vaccine developmentProceedings of the National Academy of Sciences, 2010
- Serological Correlate of Protection against Norovirus‐Induced GastroenteritisThe Journal of Infectious Diseases, 2010
- Norwalk virus-like particles as vaccinesExpert Review of Vaccines, 2010
- Molecular Epidemiology of Genogroup II-Genotype 4 Noroviruses in the United States between 1994 and 2006Journal of Clinical Microbiology, 2010
- Systematic Literature Review of Role of Noroviruses in Sporadic GastroenteritisEmerging Infectious Diseases, 2008
- An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particlesVaccine, 2008
- Virus-like particles production in green plantsMethods, 2006